1. Home
  2. BVS vs PFN Comparison

BVS vs PFN Comparison

Compare BVS & PFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BVS
  • PFN
  • Stock Information
  • Founded
  • BVS 2011
  • PFN 2004
  • Country
  • BVS United States
  • PFN United States
  • Employees
  • BVS N/A
  • PFN N/A
  • Industry
  • BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • PFN Finance/Investors Services
  • Sector
  • BVS Health Care
  • PFN Finance
  • Exchange
  • BVS Nasdaq
  • PFN Nasdaq
  • Market Cap
  • BVS 656.3M
  • PFN 663.1M
  • IPO Year
  • BVS 2021
  • PFN N/A
  • Fundamental
  • Price
  • BVS $10.01
  • PFN $7.54
  • Analyst Decision
  • BVS Strong Buy
  • PFN
  • Analyst Count
  • BVS 3
  • PFN 0
  • Target Price
  • BVS $15.00
  • PFN N/A
  • AVG Volume (30 Days)
  • BVS 240.9K
  • PFN 331.7K
  • Earning Date
  • BVS 03-11-2025
  • PFN 01-01-0001
  • Dividend Yield
  • BVS N/A
  • PFN 11.66%
  • EPS Growth
  • BVS N/A
  • PFN N/A
  • EPS
  • BVS N/A
  • PFN N/A
  • Revenue
  • BVS $555,061,000.00
  • PFN N/A
  • Revenue This Year
  • BVS $11.37
  • PFN N/A
  • Revenue Next Year
  • BVS N/A
  • PFN N/A
  • P/E Ratio
  • BVS N/A
  • PFN N/A
  • Revenue Growth
  • BVS 10.40
  • PFN N/A
  • 52 Week Low
  • BVS $3.90
  • PFN $5.94
  • 52 Week High
  • BVS $14.38
  • PFN $7.58
  • Technical
  • Relative Strength Index (RSI)
  • BVS 41.73
  • PFN 50.82
  • Support Level
  • BVS $9.74
  • PFN $7.51
  • Resistance Level
  • BVS $10.61
  • PFN $7.46
  • Average True Range (ATR)
  • BVS 0.36
  • PFN 0.05
  • MACD
  • BVS -0.06
  • PFN -0.01
  • Stochastic Oscillator
  • BVS 19.09
  • PFN 25.00

About BVS Bioventus Inc.

Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.

About PFN PIMCO Income Strategy Fund II

PIMCO Income Strategy Fund II is a closed-ended fixed income mutual fund. The company's primary investment objective is to seek high current income, consistent with the preservation of capital. The fund invests in a range of securities, such as corporate bonds and notes, non-agency mortgage-backed securities, asset-backed securities, municipal bonds and notes, short-term instruments, sovereign Issues, preferred Securities and others.

Share on Social Networks: